Literature DB >> 6695191

Perfluorochemical emulsions can increase tumor radiosensitivity.

B A Teicher, C M Rose.   

Abstract

An oxygen-carrying perfluorochemical emulsion enhanced the effectiveness of radiation therapy in two transplantable solid tumors in mice. The perfluorochemical emulsion had no effect on tumor growth after x-irradiation, but delayed tumor growth significantly when administered to oxygen-breathing mice before or during irradiation.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6695191     DOI： 10.1126/science.6695191

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  29 in total

Review 1.  Modifiers of radiosensitivity.

Authors:  A Rojas; J Denekamp
Journal:  Experientia       Date:  1989-01-15

Review 2.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

3.  Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice.

Authors:  S Rockwell; C G Irvin; M Nierenburg
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

4.  The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.

Authors:  G E Kim; C W Song
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.

Authors:  T S Herman; B A Teicher; M R Pfeffer; V S Khandekar; E Alvarez Sotomayor
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 6.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.

Authors:  B A Teicher; T S Herman; J Tanaka; B Dezube; A Pardee; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.

Authors:  B A Teicher; S A Holden; V Khandakar; T S Herman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.

Authors:  B A Teicher; T S Herman; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.

Authors:  B A Teicher; S D Bernal; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.